VIDEO – The Wild West of Stem Cells in the United States – Roberta Shapiro, DO, FAAPM&R

Dr. Roberta Shapiro, Assistant Clinical Professor at Columbia University Medical Center discusses the “Wild West of Stem Cells in the United States. She touches upon topics that include: promises of “miracle” cures for a wide variety of diseases and conditions, unwarranted warnings of danger, FDA oversight, types of stem cell treatments and [...]

Multiple Sclerosis News Today Covers Stem Cell Institute Clinical Trial for MS

Stem cells being prepared for treatment. Multiple Sclerosis News Today has published an article entitled "Treatment with Umbilical Cord Stem Cells Safe with Sustained Benefits for MS, Trial Shows". This article can be read in its entirely at MultipleSclerosisNewsToday.com.The name of the study, which is published in the Journal of Translational Medicine, is “Clinical [...]

FDA poised to outlaw breast reconstruction for breast cancer survivors using their own fat tissue

The U.S. Food and Drug Administration held public hearings for two days this week to allow for public commenting on proposed guidance relating to the regulation of human cells, tissues or tissue-based products. In its current form, this guidance will classify a woman’s own fat tissue as a drug when used in breast reconstruction procedures. [...]

2016-09-15T16:40:41+00:00September 15th, 2016|Bone Marrow Stem Cells, Breast Cancer, Cancer, FDA, News|

FDA DRAFT STEM CELL GUIDANCE DOCUMENTS EXPOSED AS IMPROPER RULEMAKING, BAD SCIENCE AND HEARTLESS PUBLIC POLICY

Go to Original Post on RickJaffe.com Today was a good day for people who want continued access stem cells outside of clinic trials, and also for people who want the FDA to allow faster access to this promising technology. There was a wide spectrum of opinions. Some stem cell companies involved in clinical trials wanted [...]

US FDA Green Lights Second Duchenne’s Muscular Dystrophy Patient To Receive Human Umbilical Cord Stem Cells In US

(PRWEB) MAY 26, 2016 After several promising treatments in Panama using stem cell technology developed by Medistem Panama Inc. at the City of Knowledge in Panama, a 6 year-old Duchenne’s muscular dystrophy patient received his first umbilical cord tissue-derived mesenchymal stem cells in the US earlier this year following FDA approval of a second application [...]

New article concludes US FDA restrictions hampering stem cell therapy progress

An article published this month in Thieme Journal of Knee Surgery entitled, "The Use of Biologic Agents in Athletes with Knee Injuries" concluded that "Biologic agents... are becoming the mainstay of nonoperative therapy in the high-demand athletic population." but "...Unfortunately, strict regulations by the FDA continue to restrict their application in clinical practice." The good [...]

First Duchenne’s Muscular Dystrophy Patient To Receive Umbilical Cord Stem Cell Therapy In US Turns 30

The first patient with Duchenne Muscular Dystrophy to be granted FDA approval for allogeneic adult stem cell therapy in the United States turned 30 this year, well surpassing his original life expectancy and paving the way for future patients, according to non-profit organization Coming Together For A Cure. Ryan Benton WICHITA, KANSAS (PRWEB) MAY [...]

Duchenne’s Patient Ryan Benton Discusses His Experience with Stem Cell Therapy

Ryan Benton is the first patient in the United States to receive human umbilical cord-derived mesenchymal stem cell therapy for Duchenne's muscular dystrophy. The US FDA granted Ryan this trial under compassionate use. Ryan first began treatments at the Stem Cell Institute in Panama before being able to receive treatments in his hometown of Wichita, [...]

2015-02-17T00:59:43+00:00February 17th, 2015|Duchenne's muscular dystrophy, News, Stem Cell Research|

After FDA Approval, Duchenne’s Muscular Dystrophy Patient Receives First Umbilical Cord Stem Cell Treatment in the United States

Ryan Benton, a 28 year-old Duchenne’s muscular dystrophy patient from Wichita, Kansas, received his first umbilical cord tissue-derived mesenchymal stem cell treatment yesterday at Asthma and Allergy Specialists of Wichita, KS following US FDA approval of his doctor’s application for a single patient, investigational new drug (IND) for compassionate use. Wichita, KS (PRWEB) September 10, [...]

Neil Riordan PhD – on opening a stem cell clinic in the United States

Stem Cell Pioneers featured Dr. Riordan in its February installment of "Ask the Doctor", a monthly segment that features stem cell scientists and doctors answering questions from readers about stem cell therapy. Over the next several days, we will share these questions and Dr. Riordan's answers with our readers. Question for Dr. Riordan: If the [...]